SCHEMBL8809347

SCHEMBL8809347

O=C1NC(=O)/C(=C/c2cn(Cc3cccc(C(F)(F)F)c3)c3ccccc23)S1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 9/20 1.00
PTPN1 P18031 3/20 0.54
TTR P02766 1/20 0.53
PIM1 P11309 1/20 0.53
CISD1 Q9NZ45 1/20 0.53
PIM2 Q9P1W9 1/20 0.53
LMNA P02545 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
MEN1 O00255 1/20 0.48
POLB P06746 1/20 0.48
HPGD P15428 1/20 0.48
HTT P42858 1/20 0.48
KMT2A Q03164 1/20 0.48
SIRT1 Q96EB6 1/20 0.48
SIRT5 Q9NXA8 1/20 0.48
ALDH1A1 P00352 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
RXRA P19793 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8809350 1.00 PARP1 (1.00) PARP1PTPN1TTRPIM1CISD1
SCHEMBL8810772 0.89 PARP1 (0.81) PARP1PTPN1PIM1PIM2LMNA
SCHEMBL8810768 0.89 PARP1 (0.81) PARP1PTPN1PIM1PIM2LMNA
SCHEMBL8811378 0.89 PARP1 (0.79) PARP1PTPN1TTRPIM1CISD1
SCHEMBL8811381 0.89 PARP1 (0.79) PARP1PTPN1TTRPIM1CISD1
SCHEMBL8809356 0.89 PARP1 (0.79) PARP1PTPN1LMNASMN1; SMN2MEN1
SCHEMBL8812784 0.87 PARP1 (0.79) PARP1TTRPIM1PIM2LMNA
SCHEMBL8690727 0.87 PARP1 (0.79) PARP1TTRPIM1PIM2LMNA
SCHEMBL8809769 0.86 PARP1 (0.81) PARP1TTRPIM1PIM2LMNA
SCHEMBL8685984 0.86 PARP1 (0.81) PARP1TTRPIM1PIM2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780389-A1 Thiazolidinedione derivatives, process for their preparation and pharmaceutical compositions containing them TOBISHI PHARMACEUTICAL CO., LTD. (JP) 1997-06-25 EP disclosed